New motorized device aims to improve hernia surgery outcomes

NCT ID NCT06710795

Ongoing Disease control Sponsor: Medtronic - MITG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times

Summary

This study is testing the MaxTack motorized fixation device, which helps surgeons attach mesh during minimally invasive ventral hernia repair. Researchers are tracking how often complications like infection or hernia recurrence happen within 3 months after surgery. The study involves 35 adults undergoing elective hernia repair.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MaxTack™ Motorized Fixation Device
What this could lead to: If successful, this device could offer a safer, more reliable way to fix mesh during hernia surgery, reducing complications like infections or hernia return.
What could go wrong: This is a small, single-arm study with only 35 participants, so results may not apply to everyone. The device could still cause side effects like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRAL HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hernia, Ventral

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRAL HERNIA

Contacts and locations

Locations

Cleveland Clinic - Ohio

Cleveland, Ohio, 44195, United States
Cleveland Clinic - Weston Hospital

Weston, Florida, 33331, United States
The Ohio State University

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.